Skip to main content

Axys Promotes Buckler To Oversee Company's Bioinformatics, Genomics

Premium

SOUTH SAN FRANCISCO, Calif.--Axys Pharmaceuticals here has promoted Alan Buckler to the position of vice-president for molecular genetics, from senior director for genomics. In the new job he will be responsible for all aspects of the company's molecular genetics program, including bioinformatics, genomics, genetics, and engineering, Axys said. Buckler will manage a staff of more than 100 at Axys's La Jolla, Calif., facility, which was formerly Sequana Therapeutics. Buckler was a founding member of Sequana's scientific advisory board.

Filed under

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.